Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Tenet Healthcare Corp (NYSE: THC) closed the day trading at $166.63 up 0.63% from the previous closing price of $165.58. In other words, the price has increased by $0.63 from its previous closing price. On the day, 0.85 million shares were traded. THC stock price reached its highest trading level at $167.77 during the session, while it also had its lowest trading level at $165.16.
Ratios:
For a better understanding of THC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.48. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.71. In the meantime, Its Debt-to-Equity ratio is 3.51 whereas as Long-Term Debt/Eq ratio is at 3.49.
On May 29, 2025, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $195.
Robert W. Baird Downgraded its Outperform to Neutral on April 15, 2025, while the target price for the stock was maintained at $137.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when FISHER RICHARD W sold 836 shares for $173.16 per share. The transaction valued at 144,762 led to the insider holds 11,292 shares of the business.
Arbour Paola M sold 7,738 shares of THC for $1,338,674 on Jun 05 ’25. The EVP, Chief Information Officer now owns 20,110 shares after completing the transaction at $173.00 per share. On Jun 05 ’25, another insider, Arbour Paola M, who serves as the Officer of the company, bought 7,738 shares for $173.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, THC now has a Market Capitalization of 14721927168 and an Enterprise Value of 29824927744. As of this moment, Tenet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.67, and their Forward P/E ratio for the next fiscal year is 10.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.81. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71 while its Price-to-Book (P/B) ratio in mrq is 3.93. Its current Enterprise Value per Revenue stands at 1.442 whereas that against EBITDA is 6.883.
Stock Price History:
The Beta on a monthly basis for THC is 1.55, which has changed by 0.090581894 over the last 52 weeks, in comparison to a change of 0.17279088 over the same period for the S&P500. Over the past 52 weeks, THC has reached a high of $185.25, while it has fallen to a 52-week low of $109.82. The 50-Day Moving Average of the stock is -0.32%, while the 200-Day Moving Average is calculated to be 14.12%.
Shares Statistics:
Over the past 3-months, THC traded about 1.62M shares per day on average, while over the past 10 days, THC traded about 1002830 shares per day. A total of 88.34M shares are outstanding, with a floating share count of 87.28M. Insiders hold about 1.22% of the company’s shares, while institutions hold 102.33% stake in the company. Shares short for THC as of 1752537600 were 2921016 with a Short Ratio of 1.80, compared to 1749772800 on 4133917. Therefore, it implies a Short% of Shares Outstanding of 2921016 and a Short% of Float of 4.4499997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 2.75. The current Payout Ratio is 0.00% for THC, which recently paid a dividend on 2000-03-13 with an ex-dividend date of 2000-03-13. Stock splits for the company last occurred on 2012-10-11 when the company split stock in a 1:4 ratio.
Earnings Estimates
As of right now, 18.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $4.05, with high estimates of $4.35 and low estimates of $3.46.
Analysts are recommending an EPS of between $16.34 and $13.22 for the fiscal current year, implying an average EPS of $15.67. EPS for the following year is $15.74, with 21.0 analysts recommending between $17.56 and $11.58.
Revenue Estimates
16 analysts predict $5.26B in revenue for the current quarter. It ranges from a high estimate of $5.35B to a low estimate of $5.19B. As of the current estimate, Tenet Healthcare Corp’s year-ago sales were $5.12BFor the next quarter, 16 analysts are estimating revenue of $5.37B. There is a high estimate of $5.52B for the next quarter, whereas the lowest estimate is $5.21B.
A total of 18 analysts have provided revenue estimates for THC’s current fiscal year. The highest revenue estimate was $21.41B, while the lowest revenue estimate was $21.05B, resulting in an average revenue estimate of $21.15B. In the same quarter a year ago, actual revenue was $20.66BBased on 20 analysts’ estimates, the company’s revenue will be $22.04B in the next fiscal year. The high estimate is $22.47B and the low estimate is $21.51B.
